# 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

> **NCT05155046** · PHASE2 · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 130 (estimated)

## Conditions studied

- Localized Prostate Cancer

## Interventions

- **DRUG:** 18F-DCFPyL

## Key facts

- **NCT ID:** NCT05155046
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-31
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155046, "18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05155046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*